Editors
Joseph S. Bertino Jr., PharmD, FCP, FCCP Principal
Bertino
Consulting
Schenectady, New York
and
Associate Professor of
Pharmacology
College of Physicians and Surgeons
Columbia
University
New York, New York
C. Lindsay
DeVane, PharmD Professor of Psychiatry and Behavioral Sciences
Medical University of South Carolina
Charleston, South Carolina
Uwe Fuhr, MD Professor of Clinical
Pharmacology
Department of Pharmacology
Faculty of Medicine at the
University of Cologne
Cologne, Germany
Angela
D. M. Kashuba, BScPhm, PharmD, DABCP Professor of Pharmacy
Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental
Therapeutics
Adjunct Professor of Medicine
School of Medicine,
Division of Infectious Diseases
The University of North Carolina at
Chapel Hill
Chapel Hill, North Carolina
Joseph
D. Ma, PharmD Assistant Professor of Clinical Pharmacy
University of California at San Diego
Skaggs School of Pharmacy &
Pharmaceutical Sciences
San Diego, California
Contributors
Shashi Amur, PhD Expert Regulatory Scientist
Genomics
Group, Office of Clinical Pharmacology,
Office of Translational
Sciences, Center for Drug
Evaluation and Research, Food Drug
Administration,
Silver Spring, Maryland
Christina
L. Aquilante, PharmD Associate Professor, Department of
Pharmaceutical
Sciences, School of Pharmacy, University of Colorado,
Denver, Aurora, Colorado
Dallas Bednarczyk,
PhD Investigator II
Department of Metabolism &
Pharmacokinetics,
Novartis Institutes for BioMedical Research, Inc.,
Cambridge, Massachusetts
Joseph S. Bertino
Jr., PharmD, FCP, FCCP Principal
Bertino Consulting
Schenectady, New York
and
Associate Professor of Pharmacology
College of Physicians and Surgeons
Columbia University
New York,
New York
Mark Bounthavong, PharmD
Pharmacoeconomics Clinical Specialist, Veterans Affairs
San Diego
Healthcare System; Health Sciences Assistant
Clinical Professor, UCSD
Skaggs School of Pharmacy
and Pharmaceutical Sciences, San Diego,
California
Stefanie P. Ferreri, PharmD, BCACP,
CDE Clinical Associate Professor, Division of Pharmacy
Practice and Experiential Education, UNC Eshelman
School of Pharmacy,
University of North Carolina at
Chapel Hill, Chapel Hill, North
Carolina
Takahisa Furuta, MD, PhD
Center for Clinical Research,
Hamamatsu University School of Medicine,
Hamamatsu, Shizuoka Prefecture, Japan
Andrea
Gaedigk, MS, PhD Associate Professor, Division of Clinical
Pharmacology
& Medical Toxicology, Children's Mercy Hospital
&
Clinics, University of Missouri-Kansas City,
Kansas City,
Missouri
Francis M. Gengo, PharmD, FCP
Associate Professor of Pharmacy and Neurology, Schools
of Pharmacy and
Medicine, State University of New
York at Buffalo; Director of Clinical
Research, Dent
Neurologic Institute, New Buffalo, New York
Christian Grimstein, PhD Clinical
Pharmacologist, Office of Clinical
Pharmacology, Office of
Translational Sciences, CDER,
U.S. Food and Drug Administration,
Silver
Spring,
Maryland
Roy L. Hawke, PharmD,
PhD Clinical Assistant Professor, Division of
Pharmacotherapy
& Experimental Therapeutics, UNC
Eshelman, School of Pharmacy,
University of North
Carolina at Chapel Hill, Chapel Hill, North
Carolina
Mary S. Hayney, PharmD, MPH, FCCP,
BCPS Professor of Pharmacy Practice, University of Wisconsin
School of Pharmacy, Madison, Wisconsin
Ogechi
Ikediobi, PharmD, PhD Assistant Professor, Department of Clinical
Pharmacy,
School of Pharmacy, University of California, San
Francisco, San Francisco, California
Melanie
S. Joy, PharmD, PhD Associate Professor of Medicine, Associate
Professor of
Pharmacy, University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina
Lawrence Lee
Soon-U, MD, PhD Assistant Professor
National University of
Singapore, National Healthcare
Group, Singapore
Sang-Seop Lee, PhD Professor, Department of Pharmacology and
Clinical
Pharmacology; Director, Pharmacogenomics Research
Center,
Inje University College of Medicine; Director,
Clinical Trial Center,
Inje University Busan Paik
Hospital, Busan, South Korea
Su-Jun Lee, PhD Professor, Department of
Pharmacology and Clinical
Pharmacology; Director, Pharmacogenomics
Research
Center, Inje University College of Medicine; Director,
Clinical Trial Center, Inje University Busan Paik
Hospital, Busan,
South Korea
Karen E. Lewis, MS, MM, CGC
Medical Policy and Technology Administrator, Priority
Health, Adjunct
Professor, Michigan State University
College of Human Medicine, Grand
Rapids, Michigan
Joseph D. Ma, PharmD
Assistant Professor of Clinical Pharmacy
University of California at
San Diego
Skaggs School of Pharmacy & Pharmaceutical Sciences
San Diego, California
Marc Maliepaard, PhD
Medicines Evaluation Board, Radboud University
Nijmegen Medical Centre,
Nijmegen, The Netherlands
and
Medicines Evaluation Board, Utrecht,
The Netherlands
Margaret Mendes, PharmD
Biologics and Pharmacogenomics Clinical Specialist,
Pharmacoeconomics
and Formulary Management,
Veterans Affairs San Diego Healthcare System,
San Diego, California
David A. Mrazek, MD,
FRCPsych Professor of Pediatrics and Psychiatry Consultant,
Department of Psychiatry and Psychology, Mayo Clinic,
Rochester,
Minnesota
Michael Murray, PhD, DSc
Professor of Pharmacogenomics, Faculty of Pharmacy,
University of
Sydney, Sydney, Australia
Anne N. Nafziger,
MD, PhD, MHS Bertino Consulting, Schenectady, New York; Adjunct
Research Professor, Department of Pharmacy Practice,
School of Pharmacy
& Pharmaceutical Sciences, State
University of New York at Buffalo,
Buffalo, New York
Julie Nangia, MD
Assistant Professor, Lester & Sue Smith Breast Cancer,
Baylor
College of Medicine, Houston, Texas
Christine
M. Nguyen, PharmD, BCPS Biologics and Pharmacogenomics Pharmacy
Resident,
Veterans Affairs San Diego Healthcare System,
San Diego,
California
Shanna K. O'Connor, PharmD,
BCPS Clinical Pharmacist, Kerr Drug, Clinical Instructor,
UNC
Eshelman School of Pharmacy, Chapel Hill,
North Carolina
Hideaki Okochi, PhD Associate Specialist, The
Drug Studies Unit, School
of Pharmacy and Medicine, University of
California,
San Francisco, San Francisco, California
Robert Lee Page II, PharmD, MSPH, FCCP, FAHA, BCPS
Associate Professor of Clinical Pharmacy & Physical
Medicine,
Clinical Specialist, Division of Cardiology,
University of Colorado,
School of Pharmacy, Denver,
Colorado
Marisa
Papaluca, MD Section Head for Scientific Support and Projects
Human Medicines Development and Evaluation Unit
European Medicines
Agency
London, United Kingdom
Markus
Paulmichl, MD Professor and Chairman, Institute of Pharmacology and
Toxicology; Director of the Helga & Erich Kellerhals
Research
Laboratories for Novel Therapeutics,
Paracelsus Medical University,
Salzburg, Austria
Michelle M. Rainka, PharmD
Adjunct Instructor, University at Buffalo School of
Pharmacy and
Pharmaceutical Sciences, Amherst,
New York
Mary W. Roederer, PharmD, BCPS Assistant Professor, UNC Eshelman
School of Pharmacy,
UNC Department of Family Medicine, Institute for
Pharmacogenomics and Individualized Therapy,
Chapel Hill, North
Carolina
Shirley K. Seo, PhD Clinical
Pharmacology Reviewer, Office of Clinical
Pharmacology, Center for
Drugs Evaluation and
Research, U.S. Food and Drug Administration,
Silver Spring, Maryland
Jae-Gook Shin, MD, PhD
Professor, Department of Pharmacology and Clinical
Pharmacology;
Director, Pharmacogenomics Research
Center, Inje University College of
Medicine; Director,
Clinical Trial Center, Inje University Busan Paik
Hospital, Busan, South Korea
Naohito Shirai,
MD, PhD Department of Gastroenterology
JA Shizuoka Kohseiren,
Enshu Hospital
Hamamatsu, Shizuoka Prefecture, Japan
Mitsushige Sugimoto, MD, PhD First Department
of Medicine
Hamamtsu University, School of Medicine
Hamamatsu,
Shizuoka Prefecture, Japan
Meghana V. Trivedi,
PharmD, PhD Assistant Professor, Department of Clinical Sciences
and
Administration, University of Houston College of
Pharmacy;
Adjunct Assistant Professor, Department of
Medicine, Lester and Sue
Smith Breast Center, Baylor
College of Medicine, Houston, Texas
Shirley M. Tsunoda, PharmD Assistant
Professor, UCSD Skaggs School of Pharmacy
and Pharmaceutical Sciences,
University of California,
San Diego, La Jolla, California
Xia Yang, PhD Principal Scientist, Group
Leader, Systems Biology,
Sage Bionetworks, Seattle, Washington